Do not let precision medicine be kidnapped

Frontiers of Medicine
|October 27, 2015
PubMed

Insights

Precision medicine, while widely supported, faces expert questions regarding its current rapid promotion. This analysis explores the concerns surrounding the vigorous advancement of precision medicine initiatives.

Area of Science:

  • Medical Science
  • Genomics
  • Pharmacology

Background:

  • The Obama administration's precision medicine initiative garnered significant attention and debate within the scientific and medical communities.
  • Precision medicine, aiming to tailor medical treatment to individual characteristics, has broad support among scientists and physicians.
  • Despite general advocacy, specific aspects and the current pace of its promotion have raised concerns among some experts.

Discussion:

  • This article acknowledges the value of precision medicine but critically examines the rapid and vigorous promotion of the initiative.
  • It highlights the need for a balanced perspective, considering potential drawbacks or premature implementation.
  • The discussion focuses on the 'incentive of vigorously promoting' rather than opposing the core concept of precision medicine.

Key Insights:

  • The majority of scientists and doctors advocate for precision medicine.
  • However, a segment of experts has voiced reservations about the concept.
  • The current aggressive push for precision medicine warrants careful consideration and debate.

Outlook:

  • Further research and discussion are needed to address the concerns surrounding the rapid implementation of precision medicine.
  • A balanced approach is crucial to ensure the responsible and effective integration of precision medicine into healthcare.
  • Future efforts should focus on addressing the specific incentives driving the current promotion of precision medicine.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
147
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112